TMHC
Taylor Morn Home
Taylor Morn Home historical holders
total: 6
Greenhaven Associates Taylor Morn Home transactions over time
- Total transactions:
- 17
- New positions:
- 2
- Sold out:
- 1
- Added:
- 6
- Reduced:
- 8
- Held since:
- 2025 Q4
- Held for:
- 2 quarters
- Latest activity:
- 2026 Q1
Edgar Wachenheim III has been an institutional investor in Taylor Morn Home (TMHC) since 2017 Q1. According to 2026 Q1 report, Edgar Wachenheim III holds 270,608 shares with a market value of roughly $15.76M representing 0.26% of their equity portfolio. The fund/company first acquired TMHC in 2017 Q1, initially purchasing 127,700 shares. Edgar Wachenheim III later completely sold out the position and reinvested in TMHC again in 2025 Q4. Since the initial investment, Greenhaven Associates has made 16 more transactions in this position.
Does Edgar Wachenheim III still hold TMHC?
Yes, Edgar Wachenheim III continues to hold Taylor Morn Home (TMHC). According to their 2026 Q1 report, they maintain a position of 270,608 shares valued at approximately $15.76M, representing 0.26% of their equity portfolio.
When did Edgar Wachenheim III first invest in TMHC?
Edgar Wachenheim III first invested in Taylor Morn Home (TMHC) in 2017 Q1 at the reported quarter-end price of $21.32 per share, acquiring 127,700 shares in their initial purchase.
What is Edgar Wachenheim III's average cost basis for TMHC?
Based on historical transaction data, Edgar Wachenheim III's estimated cost basis for Taylor Morn Home (TMHC) is approximately $58.35 per share. This represents their average reported price* across all buy transactions.
Has Edgar Wachenheim III reinvested in TMHC after selling?
Yes, Edgar Wachenheim III has shown renewed interest in Taylor Morn Home (TMHC). After completely selling their position, they reinitiated an investment in 2025 Q4, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $58.35
TMHC transactions history by Greenhaven Associates
17 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
0.26%
|
270,608
|
$58.24
|
$15,760,210
|
+469.70% (+223,108)
|
+0.21%
|
|
2025 Q4
|
0.05%
|
47,500
|
$58.87
|
$2,796,325
|
new
|
+0.05%
|
|
2020 Q3
|
0.00%
|
$19.29
|
-100% (-39,183)
|
|||
|
2020 Q2
|
0.02%
|
$19.29
|
-10.91% (-4,800)
|
|||
|
2020 Q1
|
0.02%
|
$11.00
|
-90.30% (-409,572)
|
|||
|
2019 Q4
|
0.22%
|
$21.86
|
-47.78% (-415,000)
|
|||
|
2019 Q3
|
0.46%
|
$25.94
|
-68.19% (-1,862,201)
|
|||
|
2019 Q2
|
1.00%
|
$20.96
|
-0.82% (-22,539)
|
|||
|
2019 Q1
|
0.87%
|
$17.75
|
-1.61% (-44,943)
|
|||
|
2018 Q4
|
0.86%
|
$15.90
|
-1.68% (-47,900)
|
|||
|
2018 Q3
|
0.80%
|
$18.04
|
+0.20% (+5,700)
|
|||
|
2018 Q2
|
0.88%
|
$20.78
|
-2.11% (-61,200)
|
|||
|
2018 Q1
|
1.06%
|
$23.28
|
+7.65% (+206,150)
|
|||
|
2017 Q4
|
1.00%
|
$24.47
|
+6.70% (+169,244)
|
|||
|
2017 Q3
|
0.84%
|
$22.05
|
+94.87% (+1,229,844)
|
|||
|
2017 Q2
|
0.47%
|
$24.01
|
+915.19% (+1,168,700)
|
|||
|
2017 Q1
|
0.04%
|
$21.32
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.